GSK plc (GLAXF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 11:51AM EDT
| Previous close | 22.36 |
| Open | 22.54 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 22.12 - 22.54 |
| 52-week range | 18.18 - 23.47 |
| Volume | |
| Avg. volume | 137,061 |
| Market cap | 112.633B |
| Beta (5Y monthly) | 0.29 |
| PE ratio (TTM) | 17.49 |
| EPS (TTM) | 1.26 |
| Earnings date | N/A |
| Forward dividend & yield | 0.99 (4.44%) |
| Ex-dividend date | 19 May 2022 |
| 1y target est | N/A |
- Financial Times
ViiV ‘actively negotiating’ voluntary licence for HIV prevention drug
GSK-controlled company in talks with UN-backed body on generic manufacture of highly effective PrEP injection
- Zacks
Entasis (ETTX) Stock Rises on Buyout Offer From Innoviva
Innoviva (INVA) is set to acquire Entasis (ETTX) for $2.20 per share in cash. The transaction is likely to close by third-quarter 2022.
- Zacks
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck, and Glaxo
Eli Lilly, Novo Nordisk, Merck, and Glaxo are part of Zacks Industry Outlook article.
© 2022 Yahoo. All rights reserved.
